AOA

Jacqueline Theis, OD, FAAO, discusses photophobia and how to most effectively treat this patient population, including when and how to utilizing blue light blockers.

Maria Richman, OD, FAAO, and Harvey Richman, OD, FAAO, FCOVD, met with Optometry Times to discuss their presentations on rehabilitation of a patient who suffered from issues of vertical vision after a stroke, as well as integrating patient care with the business model.

At the AOA Optometry's Meeting 2023, Jonathan Etter, MD, FAAO, presented with Susan Gromacki, OD, MS, FAAO, FSLS, on the OD and MD perspectives on keratoconus and collagen crosslinking.

Shane Swatts, OD, reviewed the key points of his course on intense pulse light therapy.

Clark Chang, OD, MSA, MSc, FAAO, meets with Optometry Times to discuss HOA-correcting scleral lens at AOA in Washingtion, DC.

Janis Winters, OD, FAAO, shares insights from her case study that she copresented during the 2023 AOA Optometry's Meeting in Washington, DC.

Louise Sclafani, OD, FAAO, FSLS, shares an exciting update on Global Ophthalmic Women (GLOW).

Marc Taub, OD, MS, FAAO, FCOVD, took a moment to speak to Optometry Times about exciting, dynamic technology that can improve experience in vision therapy rooms.

Harmin Chima, OD, met with Optometry Times to discuss treatment options for ocular surface disease with Biovance's 3-layer amniotic membrane graft.

At AOA Optometry's Meeting 2023, in Washington, DC, Justin Kwan, OD, FAAO, provides updates on the latest at CooperVision, including new data on MiSight myopia management contact lenses and information on their ortho-K software, Visavy.

Mohammad Rafieetary, OD, FAAO, shares brief highlights from his 2023 AOA presentation, "AMD updates: Staying current with its landscape," which he co-presented with Jay Haynie, OD, FAAO.

Carl Garbus, OD, FAAO, shares insights from his discussion that he copresented during the 2023 AOA Optometry's Meeting in Washington, DC.

Jacqueline Theis, OD, FAAO, shares insights from her AOA 2023 presentation on treating neurologic dry eye.

Mohammad Rafieetary, OD, FAAO, shares brief highlights from his 2023 AOA presentation, "Do you practice Eyechiatry? The psychology of vision loss," which he co-presented with Roya Attar, OD, MBA.

Roya Attar, OD, discussed, "White dot syndrome: More common than you think," which she will be presenting at AOA 2023 in Washington, DC.

Cecelia Koetting, OD, FAAO, shares insights from her AOA 2023 presentation on Demodex diaries.

Melissa Barnett, OD, FAAO, FSLS, FBCLA, shares insights from her AOA 2023 presentation on managing keratoconus in clinical practice.

Ahmad M. Fahmy, OD, FAAO, Dipl ABO, gives highlights of his AOA 2023 poster that was a pooled analysis of the Gobi and Mojave studies relevant to perfluorohexyloctane (NOV03) for dry eye disease associated with Meibomian gland dysfunction.

At the AOA Optometry's Meeting 2023, Jonathan Etter, MD, FAAO, presented with Susan Gromacki, OD, MS, FAAO, FSLS, on the OD and MD perspectives on keratoconus and collagen crosslinking.

Over the past decade the progress in retinal disease treatments has exploded with increased numbers of approved pharmaceutical compounds, resulting in more options for treating retinal disease with intravitreal agents and more are in the pipeline.

Andrew Morgenstern, OD, FAAO, FNAP, gives a brief history of the International Keratoconus Academy of Eye Care Professionals.

Mile Brujic, OD, FAAO, shares an overview of his AOA 2023 presentation, which covered 12 new treatments all optometrists should know about.

When dry eye treatments are not working for your patient’s symptoms or the anterior segment exam looks normal, you must ask yourself: What if the symptoms are secondary to a neurologic dysfunction in pain perception?

Justin Schweitzer, OD, FAAO, and Nathan Lighthizer, OD, provide key takeaways from their 2023 AOA presentation, "Beyond drops: Surgical considerations in glaucoma," which they will give alongside Walter Whitley, OD, MBA, FAAO.

Kevin Chan, OD, MS, FAAO, gives us an insider look at his AOA 2023 presentation, "Top 5 myths of myopia management and how to overcome them."

Narcotic analgesics have a role in primary eye care, however physicians must be aware of the responsibilities associated with narcotic use.

Charissa Lee discusses diversity, equity, and inclusion within her role at Johnson & Johnson Vision and in the industry overall.

Jessica Haynes, OD, shares highlights from her 2023 AOA Optometry's Meeting presentation, "Application of angiography."

Graham Erickson, OD, FAAO, FCOVD, gives key takeaways of his presentation, "Sports vision grand rounds," which he presented during the 2023 AOA Optometry's Meeting in Washington, DC.

Mile Brujic, OD, FAAO, shares an overview of his AOA 2023 presentation that discussed the pharmaceutical treatment of anterior segment inflammatory conditions.